Primenenie MMCK pri rasprostranennykh gnoynykh infektsiyakh

Genes & Cells ›› 2009, Vol. 4 ›› Issue (2) : 16 -18. DOI: 10.23868/gc121392

Articles

other

Author information +

History +

PDF

Download citation ▾

I Ya Bozo. Primenenie MMCK pri rasprostranennykh gnoynykh infektsiyakh. Genes & Cells, 2009, 4(2): 16-18 DOI:10.23868/gc121392

登录浏览全文

4963

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Le Blanc К., Ringden О. Immunomodulation by mesenchymal stem cells and clinical experience. J. Intern. Med. 2007; 262: 509-25.

[2]	Uccelli A., Pistoia V., Moretta L. Mesenchymal stem cells: A new strategy for immunosuppression? Trends Immunol. 2007; 28: 219-26.

[3]	Potian J.A., Aviv H., Ponzio N.M. et al. Veto-like activity of mesenchymal stem cells: Functional discrimination between cellular responses to alloantigens and recall antigens. J. Immunol. 2003; 171: 3426-34.

[4]	Rasmusson I., Ringden 0., Sundberg B. et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation 2003; 76: 1208-13.

[5]	Corcione A., Benvenuto F., Ferretti E. et al. Human mesenchymal stem cells modulate B-cell functions. Blood 2006; 107: 367-372.

[6]	Jiang X.X., Zhang Y., Liu B. et al. Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 2005; 105: 4120-6.

[7]	Le Blanc K., Rasmusson I., Sundberg B. et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439-41.

[8]	Kastrinaki M.C., Papadaki H.A. Mesenchymal stromal cells in rheumatoid arthritis: biological properties and clinical applications. Curr. Stem Cell Res. Ther. 2009; 4(1 ]: 61-9.

[9]	Larghero J., Vija L., Lecourt S. et al. Mesenchymal stem cells and immunomodulation: Toward new immunosuppressive strategies for the treatment of autoimmune diseases? Rev. Med. Intern. 2009; 30(3]: 287-99.

[10]	Di Nicola M., Carlo-Stella C, Magni M. et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838-43.

[11]	Aggarwal S., Pittenger M.F. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 2005; 105: 1815-22.

[12]	Hubbard W.J., Choudhry M., Schwacha M.G. et al. Cecal ligation and puncture. Shock 2005; 1: 52-7.

[13]	Rittirsch D., Huber-Lang M.S., Flier M.A. et al. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat. Protoc. 2009; 4И): 31-6.